Bio Impact Capital LLC Replimune Group, Inc. Put Options Transaction History
Bio Impact Capital LLC
- $511 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding REPL
# of Institutions
176Shares Held
78MCall Options Held
219KPut Options Held
216K-
Baker Bros. Advisors LP New York, NY11MShares$58 Million1.04% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD10.8MShares$56.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY4.71MShares$24.7 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA4.66MShares$24.5 Million5.27% of portfolio
-
Fcpm Iii Services B.V. Naarden, P73.91MShares$20.5 Million9.84% of portfolio
About Replimune Group, Inc.
- Ticker REPL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 49,306,700
- Market Cap $259M
- Description
- Replimune Group, Inc., a biotechnology company, develops oncolytic immuno-gene therapies to treat cancer. It uses its proprietary Immunotherapy platform to design and develop product candidates that are intended to activate the immune system against cancer. The company's lead product candidate is RP1, a selectively replicating version of herpes ...